Industry litigation – Page 22
-
Business
BP to pay £4.5 billion for disaster
Company will plead guilty to criminal charges including felony manslaughter
-
Business
Panel delivers final PFOA report
Probable link between perfluorooctanoic acid, used by DuPont to make fluoro-polymers, and high cholesterol
-
BusinessChemists contribute to prior art hunt
A crowdsourcing website that pays for prior art is gaining popularity – can chemists make money?
-
Business
Patent woes lead to sharp sales losses
Bristol-Myers Squibb, AstraZeneca and Eli Lilly have all suffered loss of exclusivity for key drugs
-
Business
Problems for Russian chemicals?
Accession to WTO will force government to ditch badly needed subsidies
-
Business
Teva pulls generic antidepressant
FDA rules that Budeprion XL is not equivalent to Wellbutrin XL
-
Business
Dow tax case raises R&D questions
US court blocks Dow attempt to recoup costs under the R&D tax credit scheme
-
Business
Kevlar equivalent banned for 20 years
US rules in favour of DuPont in Kevlar trade secrets case
-
BusinessCrowdsourcing science site to launch
Marblar aims to find uses for neglected patents by ‘gamifying’ the technology transfer process
-
Business
Monsanto wins $1bn in patent case
Monsanto had claimed that DuPont infringed its patents covering glyphosate pesticide products
-
Business
China to investigate polysilicon imports
An ongoing international row over the market for solar panels is spilling over into the supply chain
-
BusinessObesity drug approved in US
Qsymia from Vivus joins Belviq in a lucrative part of the pharma industry
-
BusinessInterview: EMA head Guido Rasi
Guido Rasi, head of the European Medicines Agency, wants to see greater transparency in drug development
-
Business$3bn GSK fine sets new industry record
The fine relates to off label marketing and is the largest payment of its kind ever made by a drug company
-
Business
Roche rapped for side-effect reporting failure
European medicines regulator names and shames Swiss giant for not disclosing 80,000 instances of potential adverse drug reactions
-
Business
Nasonex patent ruling goes against Merck & Co
The court ruled that the Merck patent was valid - but Apotex won’t infringe it with its product
-
BusinessDrug watchdogs mark out global territory
US and European regulatory agencies are leading worldwide collaborations to ensure drugs from outside their borders are safe
-
Business
Seroquel patent row continues
The legal tug of war over the right to sell generic versions of Seroquel (quetiapine) tablets continues
-
Business
Court throws out patent covering drug dosing
The US Supreme Court has said that medical tests that rely on correlations between drug doses and treatment cannot be patented